Back to top of page

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

1. Name of the applicant or research team

2. Contact information (email, phone number, address)

3. Title of the research project

4. A brief summary or abstract of the proposed research

5. Research plan including objectives, methods, and timeline

6. Statement addressing how the research is highly innovative or conceptually creative

7. Explanation of how the research is related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs)

8. Statement indicating if the research is a development or adaptation of revolutionary techniques or methods for addiction research, or if it tests an innovative and significant hypothesis

9. Evidence or explanation of how the research is underrepresented or not included in NIDA's current portfolio

10. Description of the potential impact of the proposed research on SUD research

11. Statement addressing the risk and potential of the research

12. Budget for the research project, including estimated costs for personnel, supplies, and any other necessary expenses

13. Curriculum vitae or resumes of the principal investigator and key personnel involved in the research

14. Letters of support or collaboration from relevant individuals or institutions if applicable

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows